Healy James
SEC-identified person · CIK 1245624 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Bioage Labs, Inc. BIOA | Director | filed 2024–2026 |
| Rapport Therapeutics, Inc. RAPP | Director | filed 2024–2026 |
| Seaport Therapeutics, Inc. SPTX | Director | filed 2026–2026 |
| Y-Mabs Therapeutics, Inc. YMAB | Director | filed 2018–2025 |
| Natera, Inc. NTRA | Director | filed 2015–2025 |
| Bolt Biotherapeutics, Inc. BOLT | Director | filed 2021–2024 |
| Karuna Therapeutics, Inc. KRTX | Director | filed 2019–2024 |
| Arrivent Biopharma, Inc. AVBP | Director | filed 2024–2024 |
| Cincor Pharma, Inc. CINC | Director | filed 2022–2023 |
| Vera Therapeutics, Inc. VERA | Officer | filed 2021–2023 |
| Coherus Oncology, Inc. CHRS | Director | filed 2014–2022 |
| Jade Biosciences, Inc. JBIO | Officer | filed 2021–2021 |
| Checkmate Pharmaceuticals, Inc. CMPI | Officer | filed 2020–2020 |
| Inozyme Pharma, Inc. INZY | Officer | filed 2020–2020 |
| Akouos, Inc. AKUS | Officer | filed 2020–2020 |
| Iterum Therapeutics plc ITRM | Director | filed 2018–2020 |
| Nextcure, Inc. NXTC | Officer | filed 2019–2019 |
| Galera Therapeutics, Inc. GRTX | Officer | filed 2019–2019 |
| Entasis Therapeutics Holdings Inc. [ETTX] | Officer | filed 2018–2018 |
| Principia Biopharma Inc. PRNB | Officer | filed 2018–2018 |
| PDS Biotechnology Corp PDSB | Director | filed 2015–2017 |
| Marinus Pharmaceuticals, INC. NASDAQMRNS | Officer | filed 2014–2016 |
| Amarin Corp PLC\UK AMRN | Director | filed 2010–2016 |
| Aclaris Therapeutics, Inc. ACRS | Officer | filed 2015–2015 |
| Synlogic, INC. SYBX | Officer | filed 2015–2015 |
| Atyr Pharma INC LIFE | Officer | filed 2015–2015 |
| Hyperion Therapeutics INC HPTX | Director | filed 2012–2015 |
| Spark Therapeutics, Inc. ONCE | Officer | filed 2015–2015 |
| Ocugen, Inc. OCGN | Officer | filed 2014–2014 |
| Intermune INC ITMN | Director | filed 2006–2014 |
| Alimera Sciences INC ALM | Officer | filed 2012–2014 |
| Aerie Pharmaceuticals INC AERI | Officer | filed 2013–2014 |
| Versartis, Inc. VSAR | Officer | filed 2014–2014 |
| Tranzyme INC TZYM | Officer | filed 2013–2014 |
| Anthera Pharmaceuticals Inc ANTH | Director | filed 2010–2013 |
| Kalobios Pharmaceuticals INC KBIOQ | Director | filed 2012–2013 |
| Durata Therapeutics, Inc. DRTX | Director | filed 2012–2012 |
| Trius Therapeutics Inc TSRX | Officer | filed 2010–2012 |
| Transcept Pharmaceuticals Inc TSPT | Director | filed 2006–2008 |
| Corgentech INC CGTK | Officer | filed 2007–2007 |
| Cotherix INC CTRX | Director | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.